The bill
To extend the SBIR and STTR programs, and for other purposes.
HR. 5100, 119th Congress — read as touching Biotech & Research.
Sponsored by
Rep. Williams, Roger [R-TX-25]
ID: W000816
Follow the money
The bill
HR. 5100, 119th Congress — read as touching Biotech & Research.
The sponsor
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
21 itemised contributions to this sponsor, pulled from FEC filings.
Track this bill's progress through the legislative process
Latest Action
Received in the Senate and Read twice and referred to the Committee on Small Business and Entrepreneurship.
September 15, 2025
📍 Current Status
Next: Both chambers must agree on the same version of the bill.
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Another masterpiece of legislative theater, courtesy of the 119th Congress. Let's dissect this farce, shall we?
**Main Purpose & Objectives:** The main purpose of HR 5100 is to extend the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs by one year. Wow, what a bold move. I'm sure it took hours of intense debate and careful consideration to decide that these programs should continue for another 12 months.
**Key Provisions & Changes to Existing Law:** The bill makes a series of minor tweaks to existing law, essentially updating expiration dates from September 30, 2025, to September 30, 2026. It's like they're trying to convince us that this is some kind of major overhaul, but really, it's just a bunch of cosmetic changes.
**Affected Parties & Stakeholders:** The affected parties include small businesses, research institutions, and government agencies involved in the SBIR and STTR programs. Oh, and let's not forget the lobbyists who will continue to reap the benefits of these programs while pretending to advocate for their clients' interests.
**Potential Impact & Implications:** The impact of this bill is negligible, but I'll play along. By extending these programs, Congress is essentially maintaining the status quo, which means that small businesses and research institutions can continue to receive funding for innovative projects. Yay, innovation! However, let's not be naive – this bill is more about perpetuating a system that benefits special interests than actually promoting meaningful change.
Now, let me put on my medical hat and diagnose the real disease here:
**Diagnosis:** Chronic legislative laziness with symptoms of bureaucratic inertia and a severe lack of vision. The underlying cause? A toxic mix of corruption, cowardice, and stupidity.
**Treatment:** None. This patient is terminal. We're just prolonging the inevitable by throwing more taxpayer dollars at these programs without addressing the systemic issues that plague our innovation ecosystem.
In conclusion, HR 5100 is a prime example of legislative malpractice – a shallow attempt to appear proactive while doing nothing to address the real problems facing small businesses and research institutions. It's time to stop pretending that this kind of legislation will lead to meaningful change and start demanding better from our elected officials.
Rep. Williams, Roger [R-TX-25]
Congress 119 • 2024 Election Cycle
No PAC contributions found
No committee contributions found
This bill has 10 cosponsors. Below are their top campaign contributors.
ID: V000081
Top Contributors
10
ID: B001291
Top Contributors
10
ID: L000397
Top Contributors
10
ID: S001212
Top Contributors
10
ID: M001204
Top Contributors
10
ID: V000134
Top Contributors
10
ID: E000071
Top Contributors
10
ID: A000379
Top Contributors
10
ID: L000598
Top Contributors
0
No contribution data available
ID: F000475
Top Contributors
10
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 55 nodes and 36 connections (39 secondary connections hidden)
Total contributions: $146,800
Showing top 19 donors by contribution amount
Which industries are materially affected by specific provisions in this bill. 4 helped.
The bill extends SBIR and STTR programs through fiscal year 2026, which provide federal funding for small business innovation research and technology transfer, directly benefiting biotech firms engaged in R&D.
SBIR/STTR extensions support small businesses in technology sectors, including semiconductors and hardware, by continuing access to federal R&D grants and contracts.
AI and cloud infrastructure startups often rely on SBIR/STTR funding for early-stage R&D; the extension maintains this funding stream through 2026.
STTR program includes provisions for military research institutions; extending it supports small defense contractors partnering with military R&D entities.